Loop Diuretics Market Size

  • Report ID: 3137
  • Published Date: Aug 30, 2024
  • Report Format: PDF, PPT

Loop Diuretics Market Size

Loop Diuretics Market size was valued at USD 2.49 billion in 2023 and is set to cross USD 5.86 billion by 2036, expanding at more than 6.8% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of loop diuretics is evaluated at USD 2.63 billion.

The growth of the market can be attributed to the growing prevalence of hypertension across the world as a result of large number of incidences of high blood pressure. Moreover, changing lifestyles and eating habits are also causing lifestyle-related diseases and several other chronic disorders, which is another factor expected to drive market growth in the coming years. According to the United Nations organization, the total number of deaths due to chronic diseases are expected to rise up to70% by 2030. The global of the burden is calculated to increase up to 56%. The demand for the loop diuretic market is also anticipated to rise significantly in the near future owing to the advancements in technology, growing cases of renal diseases, and increasing geriatric population globally. Along with these, increase in patient population and absence of appropriate treatment are evaluated to act as opportunities for market growth.


Global-Loop-Diuretics-Market-Overview
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3137
  • Published Date: Aug 30, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of loop diuretics is evaluated at USD 2.63 billion.

Loop Diuretics Market size was valued at USD 2.49 billion in 2023 and is set to cross USD 5.86 billion by 2036, expanding at more than 6.8% CAGR during the forecast period i.e., between 2024-2036. Increasing geriatric population and rising prevalence of chronic diseases will fuel the market growth.

Asia Pacific is set to dominate majority revenue share by 2036, owing to increasing prevalence of chronic diseases due to pollution and growing geriatric population in the region.

The major players in the market include Pfizer Inc., Merck & Co., Meda Manufacturing GmbH, GlaxoSmithKline plc, among others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample